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Heterozygous mutations in Myoclonin1/EFHC1 cause juvenile myoclonic epilepsy (JME), the most common
form of genetic generalized epilepsies, while homozygous F229L mutation is associated with primary intract-
able epilepsy in infancy. Heterozygous mutations in adolescent JME patients produce subtle malformations
of cortical and subcortical architecture, whereas homozygous F229L mutation in infancy induces severe
brain pathology and death. However, the underlying pathological mechanisms for these observations
remain unknown. We had previously demonstrated that EFHC1 is a microtubule-associated protein (MAP)
involved in cell division and radial migration during cerebral corticogenesis. Here, we show that JME muta-
tions, including F229L, do not alter the ability of EFHC1 to colocalize with the centrosome and the mitotic
spindle, but act in a dominant-negative manner to impair mitotic spindle organization. We also found that
mutants EFHC1 expression disrupted radial and tangential migration by affecting the morphology of radial
glia and migrating neurons. These results show how Myoclonin1/EFHC1 mutations disrupt brain develop-
ment and potentially produce structural brain abnormalities on which epileptogenesis is established.
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is the most common form
of genetic generalized epilepsies and represents 10–30% of all
epilepsies (1,2). JME typically starts during adolescence as
symmetric and asymmetric myoclonic jerks, clonic tonic–
clonic seizures and sometimes absence seizures (1,2). A
genetic contribution to JME has long been established. Twenty-
two chromosomal loci have been genetically linked with JME
(3), although mutations have been identified only in five Men-
delian genes (CACNB4, CASR, GABRA1, GABRD and Myoclo-
nin1/EFHC1. http://omim.org and http://www.ncbi.nlm.nih.
gov/omim/). Three susceptibility single-nucleotide polymorph-
isms in BRD2, Cx-36 and ME2 have also been genetically asso-
ciated with and contribute to the risk of JME (2,3).
So far, most mutations discovered in the coding sequence of
EFHC1 are heterozygous missense mutations (4–9). Rarely,
nonsense, deletions and deletions/frameshifts were also
observed (8). Heterozygous mutations in Myoclonin1/EFHC1
are to date the most frequent, reported in several unrelated
families around the world, causing 3–9% of JME including
autosomal dominant, singletons and sporadic cases (4–8).
More recently, homozygous F229L mutation in Myoclonin1/
EFHC1 was shown to produce severe drug-resistant epilepsy
in infancy starting 12–16 h after birth (10). While heterozygous
mutations in adolescent JME patients produce subtle malforma-
tions of cortical and subcortical architecture (2,11), homozygous
F229L mutation in infancy induces severe brain pathology and
death at 6 months to 3 years of age (10).
EFHC1 encodes a 70 kDa protein with three DM10
domains of unknown function and a single EF-hand motif
with a Ca2+-binding domain (4). We have previously demon-
strated that EFHC1 is a microtubule-associated protein (MAP)
that localized to the centrosome and the mitotic spindle
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through its N-terminus (12,13). We have shown that EFHC1
plays a role in cell division as its loss of function disrupts
mitotic spindles organization. Moreover, in the developing
neocortex (NCx), an acute EFHC1 deficiency impairs radial
migration of projection neurons (13).
The development of the cerebral cortex is a very complex
process, which follows strictly regulated and tightly linked
sequences of proliferation, cell cycle exit, cell migration to
specific cell layers and neuronal differentiation. Based on
their origin, there are two major types of neurons in the devel-
oping brain, excitatory projection neurons and inhibitory inter-
neurons; both types being important to maintain the balance
between excitation and inhibition in the cortex. Projection
neurons are generated in the dorsal telecephalon directly
from radial glial cells in the proliferative germinal ventricular
zone (VZ) (14–16). Radial glial cells undergo rapid prolifera-
tive divisions to expand the progenitor pool before they exit
the cell cycle. Newborn neurons move radially to the subven-
tricular zone (SVZ)-intermediate zone (IZ) where they pause
and adopt a multipolar morphology before converting to a
bipolar cell and recommencing their radial migration along
radial glial processes to reach their final position in the cortical
plate (CP) (16). Interneurons, on the other hand, originate
from ganglionic eminences of the ventral forebrain and
reach the cortex by tangential migration (15,17). Unlike radi-
ally migrating neurons, they are independent of radial glia for
their migration (18). Cells from both types move forward by
means of nucleokinesis, a saltatory process that involves
forward extension of the leading process and somal transloca-
tion to keep up (19,20).
Here, we investigate the impact of the first four JME-
causing mutations discovered (D210N, R221H, F229L and
D253Y) and two coding polymorphisms (R159W and I619L),
used as control (4) on EFHC1 function during the cell division
and cortical development. We show that, in HEK293 cells,
EFHC1 mutations do not alter the ability of the protein to
colocalize with centrosomes and mitotic spindles but induce
mitotic spindle defects. Moreover, we present evidence that
mutants EFHC1 deleteriously impact radial and tangential mi-
gration during brain development by affecting the radial glia
scaffold organization and the morphology of radially and tan-
gentially migrating neurons. Overall, our results demonstrate a
dominant-negative effect of mutations on EFHC1 properties
and identify multiple distinct roles for EFHC1 in corticogen-
esis. These findings clarify the observed microdysgenesis pro-
duced by heterozygous mutations, the severe brain pathology
created by homozygous mutations and hyperexcitable circuits
in both JME and severe epilepsy of infancy.
RESULTS
The subcellular localization of mutants EFHC1 is similar
to wild-type
As previously described for wild-type EFHC1 (12) (Fig. 1), we
examined by fluorescence imaging the subcellular distribution
in HEK293 cells of the first four mutations that have been
associated with JME by Suzuki et al. (4), i.e. D210N,
R221H, F229L and D253Y. In interphase cells, EGFP-tagged
mutants EFHC1 were observed all over the cytoplasm and in
the nucleus, except the nucleoli (Fig. 1A). Moreover, mutant
proteins colocalized with the centrosome, as shown by the
g-tubulin staining (Fig. 1A). During mitosis, all proteins asso-
ciated with the mitotic spindle (Fig. 1B). Between prophase to
late telophase, the staining was specifically located at spindle
poles (Fig. 1B and supplementary Material, S1A). It was also
observed at the spindle midzone from late anaphase to telo-
phase and at the midbody during cytokinesis (Supplementary
Material, Fig. S1A). We found the same results in the stably
transfected HEK Flp-In T-Rex-293 cell line (not shown). In
addition, we analyzed the subcellular localization of some
EFHC1 coding polymorphisms (R159W and I619L) that
were also present in healthy control population (4), and
found no difference with the wild-type protein (Fig. 1 and
Supplementary Material, Fig. S1B). Therefore, these data
showed that all mutated and polymorphic forms of EFHC1
studied present the same expression pattern as the wild-type
protein (12), indicating that they did not impair the subcellular
targeting of EFHC1.
JME mutations induce mitotic spindle defects
Based on our previous study reporting that EFHC1 loss of
function leads to abnormal mitotic spindles (13), we further
investigated the impact of EFHC1 mutations on mitosis. We,
therefore, analyzed spindle morphology in HEK293 cells
transfected with wild-type, mutants or polymorphics EGFP-
EFHC1 after a-tubulin staining (Fig. 2). We found that over-
expression of mutated forms resulted in mitotic spindle
defects, including monopolar spindle and chromosomes align-
ment failures during metaphase (chromosomes congression
abnormalities) (Fig. 2A). We quantified their occurrence in
cultures overexpressing different EGFP-tagged EFHC1 pro-
teins (Fig. 2B) and found that the percentage of abnormal spin-
dles was significantly higher for mutant proteins (65.7+ 2.2%
for D210N, 57.8+ 2.9% for R221H, 67.2+ 2.3% for F229L
and 71.3+ 4.6% for D253Y) compared with EGFP-EFHC1
(32.5+ 5.9%) or polymorphisms (36.4+ 5.6% for R159W
and 37.7+ 4.5% for I619L). We found the same results in
the stably transfected HEK Flp-In T-Rex-293 cell line (not
shown). These results suggest that mutant forms of EFHC1
could act as dominant-negative proteins that impair the
normal function of wild-type protein.
Because we have previously demonstrated that mitotic
spindle defects led to an accumulation of mitotic cells (13),
we quantified the number of mitosis in cultures expressing
EGFP, EGFP-EFHC1, EGFP-EFHC1(D253Y) (the mutant
form that gave the more important alteration of mitosis) or
EGFP-EFHC1(I619L) (Fig. 2C). We found no differences in
the mitotic index between the different above conditions.
Mutants EFHC1 impair radial migration of cortical
projection neurons
Since EFHC1 is essential for radial migration of projection
neurons during cortical development (13), we examine the
effect of its mutated forms on this process. We introduced
EGFP or EGFP-tagged wild-type, mutant and polymorphic
EFHC1 proteins into neural progenitor cells in mouse NCx
by in utero electroporation at embryonic day (E) 14.5. Three

























days later, we analyzed the distribution of EGFP-positive cells
in the VZ/SVZ, IZ and CP (Fig. 3A). As previously described
(13), no obvious differences in the spatial distribution between
EGFP and EGFP-EFHC1 transfected brains were observed
(Fig. 3A and B). However, expression of EFHC1 mutations
impaired radial migration as it resulted in the accumulation
of electroporated cells in the IZ (Fig. 3B, 45.5+ 3.4% for
D210N, 51.8+ 2.9% for R221H, 45.9+ 3.6% for F229L
and 48.9+ 2.8% for D253Y versus 38.6+ 2.2% for EFHC1
and 42.6+ 3.7% for EGFP) together with a reduced percent-
age of projection neurons in the CP (Fig. 3B, 21.8+ 4.3%
for D210N, 17.5+ 3.9% for R221H, 22.8+ 2.2% for F229L
and 18.1+ 1.9% for D253Y versus 29.8+ 1.8% for EFHC1
and 27.1+ 2.8% for EGFP). In contrast, polymorphic proteins
had no significant effect on radial migration (Fig. 3A and B).
As experiments performed on cell lines (Fig. 2), these results
point out a dominant-negative effect of mutant proteins. To
verify this hypothesis, we analyzed the migration of cells elec-
troporated with a dominant-negative form of EFHC1 contain-
ing only the microtubule-binding domain of the protein
(EGFP-N45; (13)). We found that EGFP-N45 construct inter-
fered with radial migration in the same way as mutants EFHC1
(Supplementary Material, Fig. S2), confirming the dominant-
negative effect of mutant proteins.
Mutated forms of EFHC1 does not influence progenitor
cell proliferation and cell cycle exit
Because cortical progenitor cell division occurs before and is
tightly coupled to neuronal migration, we decided to study the
influence of EFHC1 mutations on mitosis, proliferation and
cell cycle exit of cortical progenitors by in utero electropor-
ation at E14.5. As the disruption of radial migration was
similar for all mutant and polymorphic proteins, we selected
the same mutant (EGFP-EFHC1(D253Y)) and polymorphism
(EGFP-EFHC1(I619L)) as previously for further analysis.
Sections from electroporated brains collected 2 days after
electroporation were subjected to immunofluorescence to
phospho-Histone H3 (PHH3), an M-phase marker (Fig. 4A).
Similarly to cell cultures (Fig. 2C), the quantification of the
mitotic index revealed that the percentage of mitotic cells
remained unchanged after mutant protein expression com-
pared with EGFP or EGFP-EFHC1 (Fig. 4B).
We next explored whether mutants EFHC1 influence the
rate of cell cycle exit of cortical progenitors. For this
purpose, embryos were electroporated in utero at E14.5 with
EGFP, EGFP-EFHC1, EGFP-EFHC1(D253Y) or EGFP-
EFHC1(I619L), pulse labeled by a single injection of BrdU
at E15.5 and sacrificed at E16.5. Triple immunolabeling
with antibodies directed against green fluorescent protein
(GFP), BrdU and Ki67 (Fig. 4C) allowed us to establish the
cell cycle exit index. We found no difference in the percentage
of cells that had exited the cell cycle between all conditions
tested (Fig. 4D). Altogether, our results demonstrate that
mutations of EFHC1 do not influence the proliferation and
the cell cycle exit of cortical progenitors.
Mutants EFHC1 affect the morphology of radial glia and
migrating projection neurons
To better understand the observed defect in radial migration
and the accumulation of cells in the IZ induced by mutants
EFHC1, we analyzed the morphology of radial glia and mi-
grating cells within the IZ and CP (Fig. 5) 3 days after in
Figure 1. Subcellular localization of mutant and polymorphic EFHC1 proteins.
HEK293 cells expressing EGFP-tagged wild-type (EGFP-EFHC1), EGFP-
EFHC1(D253Y) or EGFP-EFHC1(I619L) (green). EGFP-EFHC1(D253Y)
and EGFP-EFHC1(I619L) images are representative of mutants and poly-
morphisms, respectively. (A) Interphase cells were stained for g-tubulin
(red) to visualize centrosomes. DNA displayed in blue. Merge panels show
that all EGFP-tagged proteins colocalized with the centrosome. (B) Mitotic
cells were stained for a-tubulin (red) to visualize microtubules. DNA dis-
played in blue. Merge panels show that all EGFP-tagged proteins associate
with the mitotic spindle. Scale bars represent 20 mm.

























utero electroporation at E14.5. In these experiments, again, we
studied one representative mutation (EGFP-EFHC1(D253Y))
and one polymorphism (EGFP-EFHC1(I619L)) together with
EGFP and EGFP-EFHC1 used as control.
Immunohistochemistry using an antibody to brain lipid-
binding protein (BLBP), a marker of radial glia, revealed a
disruption of normal radial glia architecture in the presence
of mutant protein (Fig. 5A). Brains expressing EGFP,
EGFP-EFHC1 or EGFP-EFHC1 (I619L) presented long paral-
lel radial glial fibers that terminate with tight pial end-feet. In
contrast, cortices electroporated with EGFP-EFHC1(D253Y)
showed a reduction in the extent and number of radial fibers
with few pial end-feet.
In the IZ, we quantified the number of multipolar (Fig. 5B,
arrow heads) and bipolar (Fig. 5B, arrows) cells. We showed
that the expression of EGFP-EFHC1(D253Y) leads to an accu-
mulation of multipolar cells (Fig. 5C, 76.7+ 4.54%) com-
pared with EGFP (33.1+ 5.4%), EGFP-EFHC1 (37.1+
5.3%) and EGFP-EFHC1(I619L) (44.7+ 7.4%), suggesting
a defect in the multipolar–bipolar transition.
In the CP of brains transfected with EGFP, EGFP-EFHC1
and EGFP-EFHC1(I619L), labeled cells were bipolar with
an elongated cell body and long leading processes orientated
in roughly the same direction (Fig. 5D). Though, in the pres-
ence of EGFP-EFHC1(D253Y), the leading processes seemed
to be shorter, twisted (Fig. 5D, white arrows) or harbored
several bulges (Fig. 5D, white arrow heads). Also some cells
with round-shaped cell body lacking a leading process could
be observed (Fig. 5D, red arrow heads). The quantification of
leading processes length of migrating neurons in the CP revealed
that leading processes are smaller in the presence of mutant
EFHC1 [Fig. 5E, 44.1+4.1 mm for EGFP, 47.3+4.9 mm
for EGFP-EFHC1, 39.2+4.7 mm for EGFP-EFHC1(I619L)
versus 28.6+2.4 mm for EGFP-EFHC1(D253Y)]. These
results highlight that mutants EFHC1 interfere with leading pro-
cesses extension, and thus perturb nucleokinesis of migrating
neurons. All together, our data suggest that mutants EFHC1
alter the morphology of radial glia and projection neurons at dif-
ferent steps of radial migration, resulting in their accumulation
in the IZ and impairment of their correct migration in the CP.
Mutants EFHC1 disrupt tangential migration of
interneurons
During cortical development, radial and tangential migrations
set up the arsenal of cortical cell controlling the balance
between synaptic excitation and inhibition, whose integrity
is impaired in epileptic phenomena. As we showed a role of
EFHC1 in radial migration, we therefore studied the impact
of EFHC1 and its mutations on the tangential migration of
Figure 2. EFHC1 mutations induce mitotic spindle defects. (A) Representative images of mitotic spindle defects observed in HEK293 cells expressing mutants
EGFP-EFHC1 (green). Monopolar spindle and chromosome alignment failure on metaphase plate (congression abnormality, arrows) are shown. The cells were
stained for a-tubulin (red) and DNA (blue). Scale bar represents 20 mm. (B) Quantification of abnormal spindles in cultures 2 days after transfections with EGFP,
EGFP-tagged wild-type, mutants or polymorphics EFHC1. (C) Quantification of the mitotic index 2 days after transfections with EGFP, EGFP-EFHC1, mutant
EGFP-EFHC1(D253Y) or polymorphic EGFP-EFHC1(I619L). Error bars show SEM. ∗∗P, 0.01.

























interneurons. For that purpose, we performed focal electropor-
ation directly into the median ganglionic eminence (MGE) of
rat organotypic slice cultures at E17. Three days after electro-
poration of EGFP, EGFP-tagged wild-type, mutant and poly-
morphic EFHC1 proteins, the position of electroporated cells
was noted (Fig. 6A) and the proportion of EGFP-positive
cells that had crossed the corticostriatal junction (CSJ) to
reach the NCx was quantified (Fig. 6B). The percentage of
EGFP-EFHC1 cells in the cortex was not significantly differ-
ent from EGFP (Fig. 6B, 33.09+ 1.56% versus 36.08+
1.57%, respectively), indicating that EFHC1 overexpression
has no effect on the tangential migration of interneurons in
the developing brain. On the contrary, the expression of
mutants EFHC1 induced a significant reduction of EGFP+
cells in the cortex compared with wild-type and polymorphics
EFHC1 proteins or EGFP (Fig. 6B, 13.1+ 3.6% for D210N,
15.2+ 2.9% for R221H, 15.8+ 4.5% for F229L and 12.3+
2.4% for D253Y).
We next examined the morphology of cells that had
migrated in the cortex (Fig. 6C). We found that, similarly to
projection neurons, most interneurons expressing mutants
EFHC1 displayed shorter and twisted leading processes.
[Fig. 6D, 40.6+4.1 mm for EGFP; 37.7+4.5 mm for EGFP-
EFHC1; 38.8+4.4 mm for EGFP-EFHC1(I619L) versus
25.5+4.3 mm for EGFP-EFHC1(D253Y)]. Taken altogether,
these results indicate that EFHC1 is necessary for tangential mi-
gration of interneurons, possibly by regulating cell morphology
and process formation during migration.
DISCUSSION
The principal questions in the pathophysiology of JME caused
by heterozygous mutations of EFHC1 and intractable epilepsy
of infancy due to homozygous mutations of EFHC1 are—
which function(s) of myoclonin1/EFHC1 (i) cause(s) the char-
acteristic JME myoclonic and clonic tonic–clonic seizures, (ii)
facilitate(s) the establishment of chronic epilepsy (epilepto-
genesis), (iii) produce(s) the subtle ‘microdysgenesis’ malfor-
mations of cortical and subcortical architecture in its
adolescent syndrome and severe intractable epilepsy, brain
pathology and death in its syndrome of infancy? Several, but
not mutually exclusive, hypotheses have been proposed for
the functions of EFHC1. Suzuki et al. showed that overexpres-
sion of EFHC1 in mouse hippocampal primary culture neurons
induced apoptosis by enhancing R-type voltage-dependent
Ca2+-channel currents, an effect that is reduced by mutations
(4). More recently, Katano et al. reported a molecular and
functional interaction between EFHC1 and TRPM2, a Ca2+-
permeable channel that mediates susceptibility to cell death
(21). These data suggest that EFHC1 controls cellular
calcium homeostasis and could explain how seizures are trig-
gered and how impaired apoptosis result. Additionally,
EFHC1 was shown to be expressed in tissues containing
motile cilia and flagella, such as lung, testis or ependyma, sug-
gesting a role for the protein in ciliary functions (22–25). This
was confirmed in the EFHC1-deficient mice as the ciliary
beating frequency of ependymal cells was affected in null
Figure 3. Acute expression of EFHC1 mutations alters radial migration of projection neurons in the cerebral cortex. (A) Distribution of EGFP-positive cells in
different cortical regions (VZ/SVZ, IZ and CP) 3 days after in utero electroporation at E14.5 of EGFP, EGFP-EFHC1, EGFP-EFHC1(D253Y) or
EGFP-EFHC1(I619L) (green). EGFP-EFHC1(D253Y) and EGFP-EFHC1(I619L) images are representative of mutants and polymorphisms, respectively.
EGFP-EFHC1(D253Y) panel shows radial migration defect in the CP. Scale bar represents 100 mm. (B) Quantification of EGFP-positive cells in different cor-
tical regions (VZ/SVZ, IZ and CP) 3 days after in utero electroporation at E14.5 under different above conditions. Error bars show SEM. ∗P , 0.05, ∗∗P, 0.01.

























mutants (26). In the latter suggestion, JME is considered as a
‘ciliopathy’. However, it is difficult to reconcile seizures,
much less the establishment of epileptogenesis, resulting
from a ‘ciliopathy’. In complement to the above-hypothesized
functions of EFHC1, our research group has demonstrated that
EFHC1 is a MAP that plays a role in cell division and radial
migration during neocortical development (12,13). In a
recent report, our results were confirmed when the Drosophila
homolog of EFHC1 (Defhc1.1) was also shown to be a MAP
(27). Furthermore, Defhc1.1 knockout flies displayed over-
growth of dendritic arbor, whereas overexpressing Defhc1.1
shows reduced dendrite elaboration (27). Taken together,
these in vitro and in vivo experiments demonstrate that
EFHC1 probably controls brain development by finely
tuning microtubule cytoskeleton dynamics.
In our present study, we analyzed the impact of four patho-
logical mutations (D210N, R221H, F229L and D253Y) and
two coding polymorphisms (R159W and I619L) on the prop-
erties of EFHC1 at cellular level and during the development
of the cerebral cortex. In HEK293 and stably transfected HEK
Flp-In T-Rex-293 cells, we showed that all mutated and poly-
morphic forms of EFHC1 presented the same subcellular lo-
calization of the wild-type protein, with an association with
the centrosome and the mitotic spindle. These results are not
surprising since mutations and polymorphisms are located
outside the microtubule-binding domain of EFHC1, i.e. the
first 45 amino acids of the N-terminus (13). However, we
observed that mutant proteins increased the number of abnor-
mal mitotic spindles such as monopolar spindles and congres-
sion abnormalities. Similar results have been obtained by
overexpression of EGFP-N45, a dominant-negative construct
containing only the microtubule-binding domain of EFHC1
(13). These data suggest that mutant proteins seem to
perturb functions of endogenous EFHC1 through dominant-
negative effects.
In the developing NCx, we demonstrated that acute expres-
sion of mutants EFHC1 disrupts both radial and tangential mi-
gration in a dominant-negative manner by affecting the
different steps of corticogenesis: (i) the extension of radial
glia processes, (ii) the transition from the multipolar to
Figure 4. Mutants EFHC1 do not influence proliferation and cell cycle exit of cortical progenitors. (A) Immunolabeling for PHH3 (red), a mitotic marker, of VZ/
SVZ cells in brains 2 days after in utero electroporation at E14.5 with EGFP, EGFP-EFHC1, EGFP-EFHC1(D253Y) or EGFP-EFHC1(I619L) (green). (B) Quan-
tification of the mitotic index under different above conditions. (C) Immunolabeling for BrdU (red) and Ki67 (blue), of VZ/SVZ cells in cortices 2 days after in
utero electroporation at E14.5 with EGFP, EGFP-EFHC1, EGFP-EFHC1(D253Y) or EGFP-EFHC1(I619L) (green). (D) Quantification of the cell cycle exit
index in the different above conditions. Scale bars represent 50 mm. Error bars show SEM.

























bipolar stage within the IZ and (iii) the formation of leading
processes of radially and tangentially migrating cells. These
distinct phases of migrations imply cell shape remodeling,
which largely depend on dynamic rearrangements of
microtubules (16,28–30). Several MAPs and proteins loca-
lized at the centrosome, such as Lis1 and Dcx, are direct reg-
ulators of the microtubule dynamics underlying these
morphological changes and are essential for cortical
Figure 5. Mutants EFHC1 affect the morphology of radial glia and radially migrating cells. (A) Immunolabeling for BLBP (red), a marker for radial glia, in
cortices 3 days after in utero electroporation at E14.5 with EGFP, EGFP-EFHC1, EGFP-EFHC1(D253Y) or EGFP-EFHC1(I619L). EGFP-EFHC1(D253Y)
panel shows a disruption of radial glia scaffold. (B) Morphology of cells in the IZ of brains 3 days after in utero electroporation at E14.5 with EGFP,
EGFP-EFHC1, EGFP-EFHC1(D253Y) or EGFP-EFHC1(I619L) (green). Many cells expressing EGFP, EGFP-EFHC1 or EGFP-EFHC1(I619L) are bipolar
(arrows), whereas most EGFP-EFHC1(D253Y) transfected cells remained with a multipolar morphology (arrow heads). (C) Quantification of bipolar and multi-
polar cells within the IZ under different above conditions. (D) Morphology of cells in the CP of brains 3 days after in utero electroporation at E14.5 with EGFP,
EGFP-EFHC1, EGFP-EFHC1(D253Y) or EGFP-EFHC1(I619L) (green). Cells electroporated with EGFP, EGFP-EFHC1 or EGFP-EFHC1(I619L) present long
leading processes, though EGFP-EFHC1(D253Y) transfected cells display abnormal leading processes: short and twisted (white arrows), harboring several
bulges (white arrow heads), round-shaped cell lacking a leading process (red arrow heads). (E) Quantification of leading processes length of migrating cells
within the CP under different above conditions. Scale bars represent 100 mm. Error bars show SEM. ∗P, 0.05, ∗∗P , 0.01.

























development (19,31,32). EFHC1, as a MAP, is implicated in
the same cellular pathways that regulate morphological
changes necessary for different steps of neuronal migration.
These new results presented here strengthen the hypothesis
that EFHC1 plays a role in microtubule dynamics as previous-
ly suggested (13,27). The range of defects that we observed in
neuronal migration is consistent with multiple important roles
for EFHC1 in cortical histogenesis. Obviously, the precise
mechanisms how EFHC1 is involved in radial and tangential
migrations remain to be determined.
In a previous study, we have shown that RNAi or dominant-
negative loss of EFHC1 function leads to an alteration of
radial migration with an accumulation of progenitor cells in
the VZ/SVZ following mitosis and cell cycle exit defects
(13). Our present results are slightly different as we did not
observe any default in proliferation and cell cycle exit of cor-
tical progenitors in the presence of mutants EFHC1. Cells
were capable to exit the VZ/SVZ and to migrate into the IZ
and CP, whereas some of them accumulated in the IZ. We
observed the same discrepancy in HEK293 where effects on
Figure 6. Expression of mutants EFHC1 interferes with tangential migration of interneurons. (A) Distribution of EGFP-positive cells in coronal brain slices 3
days after focal electroporation at E17 of EGFP, EGFP-EFHC1, EGFP-EFHC1(D253Y) or EGFP-EFHC1(I619L) (green). EGFP-EFHC1(D253Y) and
EGFP-EFHC1(I619L) images are representative of mutants and polymorphisms, respectively. EGFP-EFHC1(D253Y) panel shows tangential migration
defect in the cortex. Scale bar represents 200 mm. (B) Quantification of EGFP-positive cells in the cortex 3 days after focal electroporation at E17 under different
above conditions. (C) Morphology of migrating interneurons in brain slices 3 days after focal electroporation at E17 of EGFP, EGFP-EFHC1,
EGFP-EFHC1(D253Y) or EGFP-EFHC1(I619L) (green). Most EGFP-EFHC1(D253Y) expressing cells appear with a short and twisted leading process.
Scale bar represents 20 mm. (D) Quantification of leading processes length of migrating cells within the cortex under different above conditions. Error bars
show SEM. ∗P , 0.05, ∗∗P, 0.01.

























cell division were lower with mutations when compared with
RNAi or dominant-negative construct. This paradox could be
explained by a dose-dependent effect on EFHC1 impairment
where a more severe reduction in EFHC1 function was
induced by RNAi or dominant-negative construct compared
with mutated proteins. Therefore, mutants EFHC1 seem to
have mild dominant-negative effects, which would be fully
consistent with our present data. The same observation has
been made with DISC1, a MAP implicated in schizophrenia,
where DISC1 RNAi induced a more pronounced failure of
radial migration than did the addition of a
carboxy-terminal-truncated mutant of DISC1 that function in
a dominant-negative manner (33). Moreover, one has to con-
sider differences in methodologies (ex vivo electroporation
versus in utero electroporation) (34) and species (rat versus
mouse) (35) used in both the studies.
To date, several quantitative neuroimaging studies have
revealed multiple subtle structural abnormalities in JME
brains such as an increase in cortical grey matter in mesial
frontal lobes and an atrophy of the hippocampus, the thalamus
and the corpus callosum (36–39). Moreover, post-mortem
analysis of brains from JME patients has identified the pres-
ence of microscopic malformations called ‘microdysgenesis’,
characterized by the presence of cortical and subcortical dys-
topic neurons (11). These may be indicative of areas of subtle
cortical folding abnormality related to early disruption of cor-
tical development. Appropriate neuronal positioning is essen-
tial for normal neocortical function. Several studies have
shown that there is a connection between altered neuronal
positioning and establishment of epileptogenesis (32,40,41).
Moreover, subtle alterations in neuron position and/or function
have been reported to contribute to disorders such as dyslexia,
schizophrenia or mental retardation (33,42). This suggests that
JME could be a neurodevelopmental disorder that may result
from defects in neuronal integration.
All results obtained in our present work suggest that muta-
tions of EFHC1 act as dominant-negative inducing the loss of
protein functions during development with dual effects on the
clinical phenotype depending on the mode of transmission.
This functional dominant-negative effect seems to be relative-
ly mild when JME patients carry one copy of an EFHC1 mu-
tation, e.g. heterozygous transmitted as an autosomal
dominant trait. The levels of a heterozygous mutant EFHC1
in JME patients are unknown, but may well be relatively
low, producing myoclonias grand mal convulsions and
absences easily controlled by antiepileptic drugs like valproate
or levitiracetam. So, it is eminently reasonable to suggest that
partial impairment of EFHC1 function may be responsible for
the subtle ‘microdysgenesis’ in JME brains. Moreover, one
has to consider the presence of EFHC2, the paralog of
EFHC1, which could functionally compensate the absence of
EFHC1 resulting in JME patients whose cognitive functions
are normal (43). Therefore, we hypothesize that heterozygous
mutations of EFHC1 might lead to subtle deficits in the
number, composition or positioning of glutamatergic and
GABAergic neurons in the cortex, which could explain the
observed microdysgenesis, normal cognitive functions and
hyperexcitability in JME patients. A more severe
drug-intractable epilepsy with delay in psychomotor develop-
ment, brain pathology and death in infancy could also be
explained when two copies of EFHC1 mutations, e.g. homozy-
gous mutations transmitted as an autosomal recessive trait, are
present in EFHC1. Our results on the consequences of EFHC1
mutations linked to the adolescent JME phenotype and the
severe intractable epilepsy of infancy emphasizes the import-
ant and vital functions of EFHC1 in brain development,
improves our understanding of disease mechanisms in epi-




Point mutations were introduced in hEFHC1 by using the
QuickChange site-directed mutagenesis method on the
parent vectors pcDNA5/FRT/TO-EGFP-hEFHC1 or
pCAGGS-EGFP-hEFHC1 (13). All constructs were verified
by sequencing (Genotranscriptomics Platform, GIGA, Univer-
sity of Liege). The sequences of the mutagenic primers are
available upon request. Plasmid solutions were prepared
using the EndoFree plasmid purification kit (Qiagen).
Cell culture and transfections
HEK293 cells were maintained in Dulbecco’s Modified
Eagle’s Medium (Gibco) supplemented with 10% fetal
bovine serum (Greiner bio-one). Cells were grown at 378C
in a humidified incubator under 5% CO2 atmosphere. Stably
transfected HEK Flp-In T-Rex-293 cells were generated and
cultured as previously described (12). Cells were transfected
using FuGENE 6 Transfection Reagent (Roche) according to
the manufacturer’s protocol.
Animals
Time-pregnant Wistar rats (E17) and NMRI mice (E14.5)
were provided by the animal facility of the University of
Liege. They were treated according to the guidelines of
Belgian Ministry of Agriculture in agreement with European
community laboratory Animal Care and Use regulations.
In utero electroporation
In utero electroporation was performed as described previous-
ly (44). Briefly, E14.5 timed-pregnant mice were deeply
anesthetized with isoflurane in oxygen carrier (Abbot Labora-
tories Ltd). Uterine horns were exposed through a 1.5 cm inci-
sion in the ventral peritoneum and 1–3 ml of plasmid solution
(2.5 mg/ml) with 0.05% Fast Green (Sigma) were injected
through the uterus into the lateral ventricles of embryos
using a pulled glass micropipette and a microinjector (Femto-
jet, Eppendorf). Electroporation was accomplished by dischar-
ging five electrical pulses at 35 V (50 ms duration) across the
uterine wall at 1 s intervals using 5 mm platinum tweezers
electrodes (CUY650P5, Sonidel) and a square wave electro-
porator (ECM-830, BTX). Uterine horns were replaced in
the abdominal cavity and the abdomen wall and skin were
sutured using the surgical needle and thread. Buprenorphine
was injected (Temgesicw, Schering-Plough) and the animals

























were warmed on heating pads until they woke up. At different
times following the surgery, pregnant mice were sacrificed and
embryos were processed for tissue analyses.
Focal electroporation of the MGE on organotypic brain
slices
E17 time-pregnant rat were sacrificed by decapitation and
embryos were removed from the uterus. Embryonic brains
were dissected in 0.1 M phosphate-buffered saline (PBS, pH
7.4) containing 0.25 mM glucose (PBS/glucose). Brains were
embedded in 3% low-melting agarose (378C, Bio-Rad) in
PBS and incubated on ice for 1 h. Brains were cut coronally
into 300 mm slice with a vibratome (VT1000S, Leica) and
transferred onto Nucleopore track-etched membrane (0.08 mm
pore size, Whatman). Slices with their supporting membranes
were placed onto a 1% low-melting agarose gel in PBS cover-
ing a Petridish square platinum plate electrode (NEPA
GENE). One microliter of plasmid solution (2.5 mg/ml) with
0.05% Fast Green (Sigma) was injected into the MGE
region of the brain slice using a pulled glass micropipette
and a microinjector (Femtojet, Eppendorf). An agarose
column was punched with a glass Pasteur pipette from a 1%
(w/v) low-melting agarose gel in PBS and attached to a
cover square platinum plate electrode (NEPA GENE). After
adding one drop of PBS to the injected MGE region, the
column was placed onto this region and square electric
pulses (100 V, 10 ms) were passed five times with an interval
of 1 s using an electroporator (ECM 830, BTX). The electro-
porated slices on their membranes were transferred into wells
containing Neurobasal medium (Invitrogen) supplemented
with 2% B27 (Gibco), 1% N2 (Gibco), 1% penicillin/strepto-
mycin (Invitrogen) and 1% glutamine (Invitrogen). Slices
were cultured for 3 days under semidry conditions in an incu-
bator at 378C and with 5% CO2.
Tissue processing
Embryonic brains were dissected in PBS/glucose and fixed in
4% paraformaldehyde for 1 h at 48C. Cultured brain slices
were fixed in 4% paraformaldehyde for 30 min at 48C. Fixed
samples were cryoprotected in 20% sucrose in PBS overnight
at 48C, embedded in Neg 50 frozen section medium (Thermo
Scientific) and cut coronally at 20 mm onto slides (Superfrost
Plus, Thermo Scientific) with a cryostat (HM 560 M, Microm).
Immunostaining procedures
For immunostaining, we used the following primary anti-
bodies: mouse monoclonal antibody to a-tubulin (clone
B-5-2-1, Sigma, 1:2000), mouse monoclonal antibody to
g-tubulin (clone GTU-88, Sigma, 1:500), rabbit polyclonal
antibody GFP (Molecular probe, 1:2000), mouse monoclonal
antibody to bIII-tubulin (Tuj-1, Covance, 1:1000), rabbit poly-
clonal antibody to BLBP (Chemicon, 1:500), rabbit monoclo-
nal antibody to phospho-Histone H3 (PHH3, clone JY325,
Upstate, 1:500), rat monoclonal antibody to BrdU (clone
BU1/75, AbD serotec, 1:200) or mouse monoclonal antibody
to Ki67 (clone B56, BD Pharmigen, 1:50). For secondary
antibodies, we used RRX-, FITC- or Cy5-conjugated anti-
bodies to rabbit, mouse or rat IgG (Jackson ImmunoResearch,
1:500).
For immunocytochemistry, cells were grown on glass cover-
slips coated with polyornithine (0.1 mg/ml, Sigma) for 1 h at
room temperature and laminin (5 mg/ml, MP Biomedicals) for
2 h at 378C. Cells were fixed in methanol for 6 min at 2208C
or in 4% paraformaldehyde for 20 min at 48C and rinsed three
times in PBS. Cells were subsequently incubated in blocking so-
lution (0.1% Triton X-100, 1.5% nonfat dried milk in PBS) for
1h at 378C. They were incubated overnight at 48C with
primary antibodies diluted in blocking solution, washed three
times with PBS before incubation with secondary antibodies
in blocking solution for 1 h at room temperature. After three
washes in PBS, coverslips were mounted in Vectashield Hard
Set Mounting Medium with 4′,6′-diamidino-2-phe´nylindole
(DAPI, Vector laboratories). Images were captured with an
Olympus Fluoview FV1000 confocal system equipped with
an Olympus IX81 inverted microscope (Olympus) (Imaging
and Flow Cytometry Platform, GIGA, University of Lie`ge).
Images were processed using Photoshop software (Adobe
Systems).
For immunohistochemistry, cryostat sections were washed
one time with PBS and incubated 1 h at room temperature in
blocking solution [0.1% Triton X-100, 10% normal goat
serum (Jackson ImmunoResearch) in PBS]. For BrdU immu-
nostaining, sections were pretreated with 2 N HCl for
30 min at 378C followed by neutralization in Na2B4O7 for
15 min at 378C before blocking. For Ki67 immunostaining,
slices were pretreated with Target Retrieval Solution (Dako)
for 20 min at 958C before blocking. Slides were incubated
overnight at 48C with primary antibodies in blocking solution.
After three washes in PBS, sections were incubated with sec-
ondary antibodies at room temperature in blocking solution.
Slides were washed again with PBS and mounted in Vecta-
shield Hard Set Mounting Medium with DAPI. Images were
captured using an Olympus Fluoview FV1000 confocal
system equipped with an Olympus IX81 inverted microscope
(Olympus) (Imaging and Flow Cytometry Platform, GIGA,
University of Lie`ge).
Quantitative analysis
For quantification of abnormal spindles on HEK293 and HEK
Flp-In T-Rex-293, cells were counted 48 h after transfection or
doxycycline induction, respectively, in three independent experi-
ments (500 cells were randomly counted in each experiment).
For quantification of neuronal migration 3 days after in
utero electroporation, different subregions (VZ/SVZ, IZ and
CP) of the cerebral cortex were identified on the basis of
cell density visualized with DAPI nuclear staining and neuron-
al marker (b-III-tubulin) expression staining. The number of
EGFP-positive cells in different cortical subregions was
counted in two adjacent sections from six to eight independent
brains.
For quantification of the mitotic index, cryosections were
stained with anti-PHH3 antibody 48 h after in utero electro-
poration. The number of EGFP-positive and EGFP- and
PHH3-double-positive cells in the VZ/SVZ was counted in
two adjacent sections from six to eight independent brains.

























The mitotic index of EGFP-transfected cells was determined
as the ratio of EGFP-positive mitotic cells (EGFP+ and
PHH3+) to the total EGFP-positive population in the VZ/SVZ.
For cell cycle exit studies, mother mice were injected with
BrdU (50 mg/g body weight) 24 h after in utero electropor-
ation. Brains were fixed and stained with antibodies to GFP,
Ki67 and BrdU 24 h after the BrdU pulse. EGFP and BrdU
double-positive and EGFP, BrdU and Ki67 triple-positive
cells in the VZ/SVZ cells were counted in two adjacent
slices from six to eight independent embryos. The cell cycle
exit index corresponds to the percentage of EGFP-positive
cells that exited the cell cycle (EGFP+, BrdU+ and Ki672)
to total EGFP-labeled cells that incorporated BrdU (EGFP+
and BrdU+).
For quantification of tangential migration 3 days after focal
electroporation, each brain slice was divided into two regions,
i.e. the NCx and the striatum/MGE by drawing a line at the
CSJ. The number of EGFP-positive cells in the two regions
was counted in two slices from six to eight independent brains.
Statistical analyses
All experiments and quantifications were performed blind.
Statistical analysis was carried out using GraphPad Prism soft-
ware. All values are presented as mean+SEM. Statistical
analyses were performed using one-way ANOVA followed
by Dunnett’s post-hoc test for multiple comparisons. Differ-
ences between the groups were considered significant for
P, 0.05. Asterisks indicate the level of significance: ∗P,
0.05, ∗∗P, 0.01 and ∗∗∗P , 0.001.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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